# US 2017/0370939 A1 · Methods and compositions for biosensing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0370939 A1
- Document ID: US20170370939A1
- Status: Published application
- Kind: A1
- Application number: 15/630,186
- Filed: 2017-06-22
- Published: 2017-12-28
- Earliest claimed: 2016-06-22
- Assignees: The University of North Carolina at Charlotte
- Applicants: The University of North Carolina at Charlotte
- Inventors: Marcus Jones; Kirill Afonin
- Web page: https://patentgrep.com/patent/US20170370939A1

## CPC

- G01N 33/588: {with semiconductor nanocrystal label, e.g. quantum dots}
- C12Q 1/6804: Nucleic acid analysis using immunogens (immunoassay G01N33/53)
- C12Q 1/6825: Nucleic acid detection involving sensors
- G01N 21/6428: {Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53)}
- G01N 2021/6439: {with indicators, stains, dyes, tags, labels, marks}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

In one aspect, methods of sensing are described herein. In some embodiments, such a method comprises disposing a population of luminescent species in a test sample, exposing the test sample to electromagnetic radiation having a wavelength corresponding to an excitation wavelength of the luminescent species, detecting light emitted by the luminescent species within a detection region of the test sample, and correlating the light emitted by the luminescent species within the detection region to a presence or absence of an analyte within the test sample. The luminescent species, in a non-aggregated state, exhibits luminescence blinking and, in an aggregated state, does not exhibit luminescence blinking. Additionally, correlating the light emitted by the luminescent species to the presence or absence of the analyte comprises determining whether the light emitted by the luminescent species within the detection region is blinking luminescence or non-blinking luminescence.

## Claims

### Claim 1

A method of sensing, the method comprising:
disposing a population of luminescent species in a test sample;
exposing the test sample to electromagnetic radiation having a wavelength corresponding to an excitation wavelength of the luminescent species;
detecting light emitted by the luminescent species within a detection region of the test sample; and
correlating the light emitted by the luminescent species within the detection region to a presence or absence of an analyte within the test sample in an amount above a minimum detection threshold,
wherein the luminescent species, in a non-aggregated state, exhibits luminescence blinking and, in an aggregated state, does not exhibit luminescence blinking; and
wherein correlating the light emitted by the luminescent species within the detection region to the presence or absence of the analyte within the test sample comprises determining whether the light emitted by the luminescent species within the detection region is blinking luminescence or non-blinking luminescence.

### Claim 2 (depends on 1)

The method of claim 1, wherein:
the population of luminescent species, when initially disposed in the test sample, is in the non-aggregated state; and
the presence of the analyte within the test sample causes the population of luminescent species to transition from the non-aggregated state to the aggregated state, resulting in detection of non-blinking luminescence.

### Claim 3 (depends on 2)

The method of claim 2, wherein the method further comprises:
disposing an analyte binding species in the test sample prior to disposing the population of luminescent species in the test sample,
wherein the analyte binding species, in the presence of the analyte, binds to the analyte and forms a coupling species;
wherein the analyte binding species, in the absence of the analyte, does not form the coupling species; and
wherein the coupling species formed in the presence of the analyte is operable to couple a plurality of the luminescent species to one another.

### Claim 4 (depends on 3)

The method of claim 3, wherein:
individual luminescent species of the population of luminescent species comprise one or more moieties for binding to the coupling species.

### Claim 5 (depends on 3)

The method of claim 3, wherein the coupling species is operable to couple two of the luminescent species to one another.

### Claim 6 (depends on 3)

The method of claim 3, wherein the coupling species is operable to couple more than two of the luminescent species to one another.

### Claim 7 (depends on 1)

The method of claim 1, wherein:
the population of luminescent species, when initially disposed in the test sample, is in the aggregated state; and
the presence of the analyte within the test sample causes the population of luminescent species to transition from the aggregated state to the non-aggregated state, resulting in detection of blinking luminescence.

### Claim 8 (depends on 7)

The method of claim 7, wherein:
individual luminescent species in the population of luminescent species in the aggregated state are coupled to one another by one or more analyte binding species;
wherein the one or more analyte binding species, in the presence of the analyte, preferentially binds to the analyte and unbinds from the coupled individual luminescent species, thereby decoupling the individual luminescent species from one another; and
wherein the one or more analyte binding species, in the absence of the analyte, does not substantially unbind from or decouple the coupled individual luminescent species from one another.

### Claim 9 (depends on 8)

The method of claim 8, wherein:
the one or more analyte binding species couples the individual luminescent species to one another via one or more coupling moieties of the individual luminescent species.

### Claim 10 (depends on 1)

The method of claim 1, wherein the luminescent species comprise colloidal quantum dots.

### Claim 11 (depends on 1)

The method of claim 1, wherein the analyte comprises a nucleic acid.

### Claim 12 (depends on 3)

The method of claim 3, wherein:
the luminescent species, in the non-aggregated state, comprise colloidal quantum dots having one or more first coupling moieties attached to exterior surfaces of the colloidal quantum dots;
the analyte comprises a single-stranded analyte nucleic acid;
the analyte binding species comprises a double-stranded nucleic acid consisting of a single-stranded guard nucleic acid bound to a single-stranded anti-guard nucleic acid;
the anti-guard nucleic acid has a terminus comprising a toehold nucleic acid segment and comprising a second coupling moiety that is operable to selectively bind to the one or more first coupling moieties of the colloidal quantum dots;
the guard nucleic acid is operable to bind to the analyte nucleic acid;
the anti-guard nucleic acid is operable to bind to a single-stranded complementary anti-guard nucleic acid;
the complementary anti-guard nucleic acid has a terminus comprising a third coupling moiety that is operable to selectively bind to the one or more first coupling moieties of the colloidal quantum dots;
the coupling species comprises a double-stranded nucleic acid consisting of the anti-guard nucleic acid bound to the complementary anti-guard nucleic acid such that the second coupling moiety and the third coupling moiety are on opposite terminuses of the coupling species; and
binding energies of (a) the analyte nucleic acid to the guard nucleic acid, (b) the guard nucleic acid to the anti-guard nucleic acid, and (c) the anti-guard nucleic acid to the complementary anti-guard nucleic acid thermodynamically favor formation of the coupling species.

### Claim 13 (depends on 12)

The method of claim 12, wherein:
the one more first coupling moieties comprise streptavidin; and
the second coupling moiety and the third coupling moiety comprise biotin or avidin.

### Claim 14 (depends on 3)

The method of claim 3, wherein:
the luminescent species, in the non-aggregated state, comprise a colloidal quantum dot (CQD) having a first single-stranded nucleic acid (1), a second single-stranded nucleic acid (2), and a third single-single stranded nucleic acid (3) attached to an exterior surface of the CQD;
the analyte comprises a single-stranded analyte nucleic acid having a first binding moiety (p1′), a second binding moiety (p2′), and a third binding moiety (p3′);
the analyte binding species comprises a first single-stranded nucleic acid (p1) bound to a first complementary single-stranded nucleic acid (1′) attached to a first quantum dot (QD1), a second single-stranded nucleic acid (p2) bound to a second complementary single-stranded nucleic acid (2′) attached to a second quantum dot (QD2), and a third single-stranded nucleic acid (p3) bound to a third complementary single-stranded nucleic acid (3′) attached to a third quantum dot (QD3);
(p1′) is operable to bind to (p1);
(p2′) is operable to bind to (p2);
(p3′) is operable to bind to (p3);
(1′) is operable to bind to (1);
(2′) is operable to bind to (2);
(3′) is operable to bind to (3);
the coupling species comprises a species in which (1′) is bound to (1), (2′) is bound to (2), and (3′) is bound to (3); and
binding energies of (p1′) bound to (p1), (p2′) bound to (p2), (p3′) bound to (p3), (1′) bound to (1), (2′) bound to (2), and (3′) bound to (3) thermodynamically favor formation of the coupling species.

### Claim 15 (depends on 8)

The method of claim 8, wherein:
the coupled individual luminescent species comprise a colloidal quantum dot (CQD) bound to a first additional quantum dot (QD1), a second additional quantum dot (QD2), and a third additional quantum dot (QD3);
the CQD has a first single-stranded nucleic acid (1), a second single-stranded nucleic acid (2), and a third single-single stranded nucleic acid (3) attached to an exterior surface of the CQD;
the analyte binding species comprise a first single-stranded nucleic acid (p1) bound to a first complementary single-stranded nucleic acid (1′) attached to the QD1 and to (1), a second single-stranded nucleic acid (p2) bound to a second complementary single-stranded nucleic acid (2′) attached to the QD2 and to (2), and a third single-stranded nucleic acid (p3) bound to a third complementary single-stranded nucleic acid (3′) attached to the QD3 and to (3);
the analyte comprises a single-stranded analyte nucleic acid having a first binding moiety (p1′), a second binding moiety (p2′), and a third binding moiety (p3′); and
binding energies of (p1′) bound to (p1), (p2′) bound to (p2), (p3′) bound to (p3), (1′) bound to (1), (2′) bound to (2), and (3′) bound to (3) thermodynamically favor the decoupling of the QD1, the QD2, and the QD3 from the CQD.

### Claim 16

A sensing composition, the composition comprising:
a population of individual luminescent species;
wherein the luminescent species, in a non-aggregated state, exhibits luminescence blinking and, in an aggregated state, does not exhibit luminescence blinking; and
wherein the individual luminescent species are operable to transition from the non-aggregated state to the aggregated state in the presence of an analyte.

### Claim 17 (depends on 16)

The composition of claim 16, wherein the individual luminescent species comprise colloidal quantum dots.

### Claim 18

A sensing composition, the composition comprising:
a coupled luminescent species formed from an aggregate of individual luminescent species;
wherein the individual luminescent species, in a non-aggregated state, exhibit luminescence blinking and, in an aggregated state, do not exhibit luminescence blinking; and
wherein the coupled luminescent species is operable to transition from the aggregated state to the non-aggregated state in the presence of an analyte.

### Claim 19 (depends on 18)

The composition of claim 18, wherein the individual luminescent species comprise colloidal quantum dots.

### Claim 20 (depends on 18)

The composition of claim 18, wherein:
the coupled individual luminescent species comprise a colloidal quantum dot (CQD) bound to a first additional quantum dot (QD1), a second additional quantum dot (QD2), and a third additional quantum dot (QD3);
the CQD has a first single-stranded nucleic acid (1), a second single-stranded nucleic acid (2), and a third single-single stranded nucleic acid (3) attached to an exterior surface of the CQD;
the analyte binding species comprise a first single-stranded nucleic acid (p1) bound to a first complementary single-stranded nucleic acid (1′) attached to QD1 and to (1), a second single-stranded nucleic acid (p2) bound to a second complementary single-stranded nucleic acid (2′) attached to QD2 and to (2), and a third single-stranded nucleic acid (p3) bound to a third complementary single-stranded nucleic acid (3′) attached to QD3 and to (3);
the analyte comprises a single-stranded analyte nucleic acid having a first binding moiety (p1′), a second binding moiety (p2′), and a third binding moiety (p3′); and
binding energies of (p1′) bound to (p1), (p2′) bound to (p2), (p3′) bound to (p3), (1′) bound to (1), (2′) bound to (2), and (3′) bound to (3) thermodynamically favor the decoupling of the QD1, the QD2, and the QD3 from the CQD.
